Henry Schein (HSIC) Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Henry Schein (Nasdaq: HSIC) reported third-quarter 2026 sales of $3.5 billion, up 4.0% overall and 3.1% internally in local currencies, with GAAP earnings per share rising 26.2% year over year and non-GAAP EPS up 13.0%, or 19.1% excluding current-quarter items. The Melville, N.Y.-based dental and medical solutions provider also raised its full-year 2026 guidance. The results matter because they show the company sustaining internal growth and margin expansion despite a modest top-line pace, while the guidance increase signals management expects momentum to continue. Investors will watch whether the raised outlook holds through the fourth quarter and how internal growth trends evolve.
Muhabbit's AI wrote this summary in its own words from Business Wire's report. It can get details wrong, so check the source.
Named in this story
Henry Schein, Inc., Henry Schein (HSIC)
A linked name opens that asset's sentiment page.